Michael Petusky
Stock Analyst at Barrington Research
(2.22)
# 2,595
Out of 4,784 analysts
187
Total ratings
40.61%
Success rate
-5.07%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIK Anika Therapeutics | Maintains: Outperform | $25 → $20 | $15.11 | +32.36% | 16 | Mar 13, 2025 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 | $1.70 | +32.35% | 13 | Mar 12, 2025 | |
| VRME VerifyMe | Maintains: Outperform | $1.5 → $1.25 | $0.67 | +86.29% | 9 | Mar 7, 2025 | |
| MODV ModivCare | Maintains: Outperform | $10 → $6 | $1.40 | +330.11% | 14 | Mar 7, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $24 → $20 | $14.93 | +33.96% | 20 | Feb 28, 2025 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $108 → $98 | $71.93 | +36.24% | 22 | Feb 28, 2025 | |
| LMAT LeMaitre Vascular | Downgrades: Market Perform | n/a | $83.05 | - | 9 | Feb 28, 2025 | |
| OPCH Option Care Health | Maintains: Outperform | $33 → $38 | $34.73 | +9.42% | 13 | Feb 27, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $115 → $111 | $103.94 | +6.79% | 18 | Feb 26, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $90 | $68.62 | +31.16% | 13 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $95 | $63.19 | +50.34% | 28 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.85 | - | 6 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $30.75 | - | 6 | May 30, 2024 |
Anika Therapeutics
Mar 13, 2025
Maintains: Outperform
Price Target: $25 → $20
Current: $15.11
Upside: +32.36%
OPKO Health
Mar 12, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.70
Upside: +32.35%
VerifyMe
Mar 7, 2025
Maintains: Outperform
Price Target: $1.5 → $1.25
Current: $0.67
Upside: +86.29%
ModivCare
Mar 7, 2025
Maintains: Outperform
Price Target: $10 → $6
Current: $1.40
Upside: +330.11%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $14.93
Upside: +33.96%
U.S. Physical Therapy
Feb 28, 2025
Maintains: Outperform
Price Target: $108 → $98
Current: $71.93
Upside: +36.24%
LeMaitre Vascular
Feb 28, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $83.05
Upside: -
Option Care Health
Feb 27, 2025
Maintains: Outperform
Price Target: $33 → $38
Current: $34.73
Upside: +9.42%
Merit Medical Systems
Feb 26, 2025
Maintains: Outperform
Price Target: $115 → $111
Current: $103.94
Upside: +6.79%
Henry Schein
Feb 26, 2025
Maintains: Outperform
Price Target: $90
Current: $68.62
Upside: +31.16%
Feb 7, 2025
Maintains: Outperform
Price Target: $108 → $95
Current: $63.19
Upside: +50.34%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $6.85
Upside: -
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $30.75
Upside: -